Boothbay Fund Management »

First Tracks Biotherapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $264k 13k 20.12

More positions owned by Boothbay Fund Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Tesla Motors Call Option (TSLA)
Vaxcyte (PCVX)
Constellation Brands Cl A Call Option (STZ)
Apple Call Option (AAPL)
Advanced Micro Devices Call Option (AMD)
Cornerstone Strategic Value (CLM)
Liquidia Corporation Com New (LQDA)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)

View all positions for Boothbay Fund Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics